References
- Dunn J. Cataract surgery in patients with uveitic cataract. Tech Ophthalmol. 2009;7:3–7
- Okhravi N, Lightman S, Towler H, et al. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology. 1999;106:710–722
- Foster C, Fong L, Singh G. Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology. 1989;96:281–285
- Barton K, Hall A, Rosen P, et al. Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocular Immunol Inflamm. 1994;2:207–216
- Laurell C, Zetterstorm C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Br J Ophthalmol. 2002;86:1380–1384
- Foster C, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol. 2003;14:1–6
- Ram J, Gupta A, Kumar S, et al. Phacoemulsification with intraocular lens implantation in eyes with uveitis. J Cataract Refract Surg. 2010;36:283–288
- Estafanous M, Lowder C, Meisler D, et al. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001;131:620–625
- Krishna R, Meisler D, Lowder C, et al. Long term follow-up of extracapsular cataract extraction and posterior chamber intraocular lens implantation in patients with uveitis. Ophthalmology. 1998;105:1765–1769
- Van Kooij B, Rothova A, de Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm. 2006;14:73–85
- Dada T, Dhawan M, Garg S, et al. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. J Cataract Refract Surg. 2007;33:1613–1618
- Okhravi N, Morris A, Kok S, et al. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract. J Cataract Refractive Surg. 2007;33:1278–1283
- Chieh J, Carlson A, Jaffe G. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. Am J Ophthalmol. 2008;146:589–594
- Haller J, Bandello F, Belfort R, et al. Randomized sham controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134–1146
- Kuppermann B, Blumenkranz M, Haller J, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309–317
- Haller J, Kuppermann B, Blumenkranz M, et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010;128:289–296
- Williams G, Haller J, Kuppermann B, et al. Dexamethasone posterior drug delivery system in treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147:1048–1054
- Meyer LM, Schonfeld CL. Cystoid macular edema after complicated cataract surgery resolved by intravitreal dexamethasone 0.7 mg implant. Case Rep Ophthalmol. 2011;2:319–322
- Tranos P, Wickremasinghe S, Stangos N, et al. Macular edema. Surv Ophthalmol. 2004;49:470–490
- Paganelli F, Cardillo J, Melo LA Jr, et al. A single intraoperative sub-Tenons capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology. 2004;111:2102–2108
- Chang-Lin J, Attar M, Acheampong A, et al. Pharmacokinetics and pharmacodynamics of the sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;5:80–86